271 related articles for article (PubMed ID: 20497908)
1. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease.
Morawski M; Brückner G; Jäger C; Seeger G; Arendt T
Neuroscience; 2010 Sep; 169(3):1347-63. PubMed ID: 20497908
[TBL] [Abstract][Full Text] [Related]
2. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
3. Aggrecan-based extracellular matrix shows unique cortical features and conserved subcortical principles of mammalian brain organization in the Madagascan lesser hedgehog tenrec (Echinops telfairi Martin, 1838).
Morawski M; Brückner G; Jäger C; Seeger G; Künzle H; Arendt T
Neuroscience; 2010 Feb; 165(3):831-49. PubMed ID: 19682554
[TBL] [Abstract][Full Text] [Related]
4. Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice.
Morawski M; Pavlica S; Seeger G; Grosche J; Kouznetsova E; Schliebs R; Brückner G; Arendt T
Neurobiol Aging; 2010 Jul; 31(7):1254-6. PubMed ID: 18829133
[TBL] [Abstract][Full Text] [Related]
5. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease.
Baig S; Wilcock GK; Love S
Acta Neuropathol; 2005 Oct; 110(4):393-401. PubMed ID: 16133543
[TBL] [Abstract][Full Text] [Related]
6. The neuronal extracellular matrix restricts distribution and internalization of aggregated Tau-protein.
Suttkus A; Holzer M; Morawski M; Arendt T
Neuroscience; 2016 Jan; 313():225-35. PubMed ID: 26621125
[TBL] [Abstract][Full Text] [Related]
7. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
8. Aggrecan-based extracellular matrix is an integral part of the human basal ganglia circuit.
Brückner G; Morawski M; Arendt T
Neuroscience; 2008 Jan; 151(2):489-504. PubMed ID: 18055126
[TBL] [Abstract][Full Text] [Related]
9. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
10. Perineuronal nets potentially protect against oxidative stress.
Morawski M; Brückner MK; Riederer P; Brückner G; Arendt T
Exp Neurol; 2004 Aug; 188(2):309-15. PubMed ID: 15246831
[TBL] [Abstract][Full Text] [Related]
11. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
Arendt T; Brückner MK; Bigl V; Marcova L
J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112
[TBL] [Abstract][Full Text] [Related]
12. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
13. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001
[TBL] [Abstract][Full Text] [Related]
14. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
Boutajangout A; Boom A; Leroy K; Brion JP
FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583
[TBL] [Abstract][Full Text] [Related]
16. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
17. Distribution and classification of aggrecan-based extracellular matrix in the thalamus of the rat.
Gáti G; Morawski M; Lendvai D; Jäger C; Négyessy L; Arendt T; Alpár A
J Neurosci Res; 2010 Nov; 88(15):3257-66. PubMed ID: 20857510
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
19. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
[TBL] [Abstract][Full Text] [Related]
20. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
